What does VAN RENGEN - VERSELE do?

VAN RENGEN - VERSELE is a pharmacy in Horebeke. Private Limited, started on 10 October 2006, 1 establishment.

What is the address of VAN RENGEN - VERSELE?

The registered office of VAN RENGEN - VERSELE is located at Dorpsstraat 53, 9667 Horebeke.

Is VAN RENGEN - VERSELE still active?

Yes. According to the CBE (31 October 2026) VAN RENGEN - VERSELE is active, legal situation “Normale toestand”, started on 10 October 2006.

Is VAN RENGEN - VERSELE registered on Peppol?

Yes, VAN RENGEN - VERSELE is registered on the Peppol network with ID 0208:0884115408.

What is the enterprise number of VAN RENGEN - VERSELE?

The enterprise number of VAN RENGEN - VERSELE is BE0884115408.

When was VAN RENGEN - VERSELE founded?

VAN RENGEN - VERSELE was founded on 10 October 2006.

Who are the directors of VAN RENGEN - VERSELE?

According to the 2026 annual accounts, the directors of VAN RENGEN - VERSELE are: Bart Van Rengen, Laurence Versele.

Is VAN RENGEN - VERSELE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 October 2006; 5 annual accounts filed, latest fiscal year 2026; 2 directors known from the annual account.

How much profit did VAN RENGEN - VERSELE make in 2026?

VAN RENGEN - VERSELE posted a profit after taxes of € 130,770 in financial year 2026.

What is the revenue of VAN RENGEN - VERSELE?

As a small company, VAN RENGEN - VERSELE is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 163,052.

Does VAN RENGEN - VERSELE have a website?

Yes, VAN RENGEN - VERSELE has a website at apotheekvanrengen.be.

VAN RENGEN - VERSELE (Private Limited) - Horebeke

Dossier VAN RENGEN - VERSELE, printed on 31 October 2026 from databakkes.be/en/0884115408/van-rengen-versele. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 38 % of short-term debt in 2026; threshold 65 %.

Financials

Financial year 2026

VAN RENGEN - VERSELE from Horebeke, company number BE0884115408, closed financial year 2026 with a result of € 130,770 after tax. For that financial year VAN RENGEN - VERSELE recorded a gross margin of € 163,052 and equity of € 1.6 million. Compared with financial year 2025, the result moved from € 190,760 to € 130,770. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 28, 2026.

What it is worth Growing

€ 1.6 million

▲ 9% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 130,770

▼ 31% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 78,660

▼ 53% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1,600 paid out

1 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2026

Bank debt

€ 8,546

▼ 62% vs 2025

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 2,272

▼ 69% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 12,426

▼ 53% vs 2025

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 171,052 Gross margin 2023: € 171,052 First fiscal year in the series	€ 169,375 Gross margin 2024: € 169,375 ▼ 1% vs 2023 (€ 171,052) Unfavourable step	€ 188,473 Gross margin 2025: € 188,473 ▲ 11% vs 2024 (€ 169,375) Favourable step	€ 163,052 Gross margin 2026: € 163,052 ▼ 13% vs 2025 (€ 188,473) Unfavourable step	▼ 13%
Profit after taxes	€ 89,046 Profit after taxes 2023: € 89,046 First fiscal year in the series	€ 174,938 Profit after taxes 2024: € 174,938 ▲ 96% vs 2023 (€ 89,046) Favourable step	€ 190,760 Profit after taxes 2025: € 190,760 ▲ 9% vs 2024 (€ 174,938) Favourable step	€ 130,770 Profit after taxes 2026: € 130,770 ▼ 31% vs 2025 (€ 190,760) Unfavourable step	▼ 31%
Equity	€ 1,198,360 Equity 2023: € 1,198,360 First fiscal year in the series	€ 1,245,855 Equity 2024: € 1,245,855 ▲ 4% vs 2023 (€ 1,198,360) Favourable step	€ 1,435,015 Equity 2025: € 1,435,015 ▲ 15% vs 2024 (€ 1,245,855) Favourable step	€ 1,564,185 Equity 2026: € 1,564,185 ▲ 9% vs 2025 (€ 1,435,015) Favourable step	▲ 9%
Total debts	€ 476,250 Total debts 2023: € 476,250 First fiscal year in the series	€ 513,037 Total debts 2024: € 513,037 ▲ 8% vs 2023 (€ 476,250) Unfavourable step	€ 432,419 Total debts 2025: € 432,419 ▼ 16% vs 2024 (€ 513,037) Favourable step	€ 353,692 Total debts 2026: € 353,692 ▼ 18% vs 2025 (€ 432,419) Favourable step	▼ 18%
Cash	€ 116,371 Cash 2023: € 116,371 First fiscal year in the series	€ 100,536 Cash 2024: € 100,536 ▼ 14% vs 2023 (€ 116,371) Unfavourable step	€ 167,582 Cash 2025: € 167,582 ▲ 67% vs 2024 (€ 100,536) Favourable step	€ 78,660 Cash 2026: € 78,660 ▼ 53% vs 2025 (€ 167,582) Unfavourable step	▼ 53%
Land & buildings	€ 877,476 Land & buildings 2023: € 877,476 First fiscal year in the series	€ 873,374 Land & buildings 2024: € 873,374 Unchanged (€ 877,476) Unchanged	€ 853,741 Land & buildings 2025: € 853,741 ▼ 2% vs 2024 (€ 873,374) Unchanged	€ 1,296,631 Land & buildings 2026: € 1,296,631 ▲ 52% vs 2025 (€ 853,741) Unchanged	▲ 52%
Retained profit	€ 1,123,360 Retained profit 2023: € 1,123,360 First fiscal year in the series	€ 1,170,855 Retained profit 2024: € 1,170,855 ▲ 4% vs 2023 (€ 1,123,360) Favourable step	€ 1,360,015 Retained profit 2025: € 1,360,015 ▲ 16% vs 2024 (€ 1,170,855) Favourable step	€ 1,489,185 Retained profit 2026: € 1,489,185 ▲ 9% vs 2025 (€ 1,360,015) Favourable step	▲ 9%
Dividend	€ 96,637 Dividend 2023: € 96,637 First fiscal year in the series	€ 127,443 Dividend 2024: € 127,443 ▲ 32% vs 2023 (€ 96,637) Unchanged	€ 1,600 Dividend 2025: € 1,600 ▼ 99% vs 2024 (€ 127,443) Unchanged	€ 1,600 Dividend 2026: € 1,600 Unchanged (€ 1,600) Unchanged
Bank debt	€ 73,907 Bank debt 2023: € 73,907 First fiscal year in the series	€ 36,298 Bank debt 2024: € 36,298 ▼ 51% vs 2023 (€ 73,907) Favourable step	€ 22,716 Bank debt 2025: € 22,716 ▼ 37% vs 2024 (€ 36,298) Favourable step	€ 8,546 Bank debt 2026: € 8,546 ▼ 62% vs 2025 (€ 22,716) Favourable step	▼ 62%
Balance sheet total	€ 1,674,610 Balance sheet total 2023: € 1,674,610 First fiscal year in the series	€ 1,758,892 Balance sheet total 2024: € 1,758,892 ▲ 5% vs 2023 (€ 1,674,610) Unchanged	€ 1,867,434 Balance sheet total 2025: € 1,867,434 ▲ 6% vs 2024 (€ 1,758,892) Unchanged	€ 1,917,877 Balance sheet total 2026: € 1,917,877 ▲ 3% vs 2025 (€ 1,867,434) Unchanged	▲ 3%

Key figures of VAN RENGEN - VERSELE, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to VAN RENGEN - VERSELE?

What happened at VAN RENGEN - VERSELE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 28, 2026 New annual accounts for financial year 2026: profit of € 130,770 (▼ 31% vs 2025). Source: NBB ↗
Oct 23, 2006 New establishment in Horebeke. KBO
Oct 10, 2006 Start of the company according to the CBE. KBO

In short

From € 89,046 profit in 2023 to € 130,770 profit in 2026.

Paid € 156,933 in corporate taxes since 2023.

Best year ever: 2025, with € 190,760 profit.

Paid out € 227,280 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Bart Van Rengen

Laurence Versele

VAN RENGEN - VERSELE

apotheek van rengen

Behind VAN RENGEN - VERSELE are Bart Van Rengen and Laurence Versele. It owns apotheek van rengen itself.

Directors

According to the 2026 annual accounts

Bart Van Rengen

Director

Also active at: APOTHEEK VAN RENGEN

Laurence Versele

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpsstraat 53

9667 Horebeke

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

APOTHEEK VAN RENGEN same network

€ 178,682 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekvanrengen.be

About

Technologies

AvadaContact Form 7Facebook PixelFont AwesomeGoogle FontsGoogle MapsNginxPHPWordPressjQueryreCAPTCHA

Hosting & Email

Email provider

Microsoft 365

Hosting

DSTNY-BACKBONE International Backbone, BE

Website info

HTTPS Ja

Languages NL

Features

Webshop Blog Ads Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number

0884.115.408

VAT number

BE 0884.115.408

Registered office

Dorpsstraat 53, 9667 Horebeke

Names & denominations

VAN RENGEN - VERSELE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

10 October 2006

Peppol

Active · Active since 28 Dec 2025

Contact

apotheekvanrengen.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Activiteiten van holdings

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Managementactiviteiten van holdings

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

VAN RENGEN - VERSELE

Warning lights

Financials

What happened to VAN RENGEN - VERSELE?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Details

Frequently asked questions